IncFact
Company Profiles: Revenue, Growth, Competition

GENEOS THERAPEUTICS Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for GENEOS Therapeutics

Access the complete profile.

GENEOS Therapeutics Fast Facts

Revenue$1 - $10 million    See Exact Annual Revenue
Employees1 - 10Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes541715
Address660 West Germantown Pike Suite 110
Plymouth Meeting, PA 19462

Note: Revenues for privately held companies are statistical evaluations.


GENEOS Therapeutics's annual revenues are $1-$10 million (see exact revenue data) and has 1-10 employees. It is classified as operating in the Scientific Research & Development Services industry.


GENEOS Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

GENEOS Therapeutics Annual Revenue and Growth Rate

GENEOS Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report
2018
2017
2016
2015
2014


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: GENEOS Therapeutics's revenues are gauged from an analysis of company filings.



Investor Activity

GENEOS Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
November 17, 2020 4 87%$12 MM
Complete list of funding rounds and total amounts in the Company Report




GENEOS Therapeutics's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
GENEOS Therapeutics Revenue (Sales) GENEOS Therapeutics Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that GENEOS Therapeutics is developing and marketing. GENEOS Therapeutics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
GT-EPIC
Therapeutic pharmaceuticals for the personalized treatment of cancer and oncological conditions; pharmaceuticals, namely, immunotherapies for the personalized treatment of cancer and oncological conditions; immunotherapy products, namely, pharmaceutical products for the personalized treatment of cancer and oncological conditions
07/22/2019
GENEOS THERAPEUTICS
Research and development in the fields of pharmaceuticals, biopharmaceuticals and therapeutics; Research and development in the field of personalized medicine and its delivery to patients; Research and development in the field of oncology; Research and development of personalized cancer treatments; Medical and scientific research, namely, conducting clinical trials for others; Research and development of treatments for infectious diseases
01/04/2017

See all trademarks and details in the Full Report.


Recession Risk

Determine whether GENEOS Therapeutics grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof GENEOS Therapeutics is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Scientific Research & Development Services

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of GENEOS Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as GENEOS Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
OMNICARECincinnati, OH100 
LEIDOSReston, VA91 
INC RESEARCHMorrisville, NC62 
SCIENCE APPLICATIONS INTERNATIONALReston, VA61 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM47 
CEPHALONFrazer, PA44 
SYNEOS HEALTHRaleigh, NC29 
INCYTEWilmington, DE29 
COVANCEPrinceton, NJ27 




Nearby Competitors

These companies are similar in business line and location to GENEOS Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
GLOBUS MEDICAL NORTH AMERICAAudubon, PA100 
BTG INTERNATIONALWest Conshohocken, PA23 
PSI PHARMA SUPPORT AMERICAKing Of Prussia, PA7 
PVR TECHNOLOGIESKng Of Prussa, PA5 
BEHAVIOR INTERVENTIONSKing Of Prussia, PA3 
ROCKLAND IMMUNOCHEMICALSLimerick, PA3 




Future Competition: GENEOS Therapeutics's Fastest Growing Competitors

These companies are in the same general field as GENEOS Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
GENEOS Therapeutics Competitors